Endocannabinoids (eCBs) play a role in the modulation of neuroinflammation, and experimental findings suggest that they may be directly involved in the pathogenesis of multiple sclerosis (MS). The objective of our study was to measure eCB levels in the cerebrospinal fluid (CSF) of patients with MS.
Centre for Study of Demyelinating Diseases, Department of Medical and Surgical Specialities and Public Health, Ospedale S Maria della Misericordia, University of Perugia, Perugia, Italy.
